AccuRna Inc. (NANOCARRIER CO. LTD.)
Company Snapshot
Company Overview
NanoCarrier Co., Ltd. (NC) is a 12-year-old biotechnology company that is developing and manufacturing anti-cancer drugs using micelle nanoparticle technology. The technology employs nanoparticles that are constructed from biocompatible block polymers. These are combinations of hydrophilic polyethylene glycol (PEG) and hydrophobic polyamino acids. The company has a presence in Asia and Europe as well as in Japan. Revenues come primarily from licensing and development agreements between NC and other pharmaceutical companies. NanoCarrier and its partners filed investigational new drug (IND) applications for four clinical trials that were subsequently launched after receiving approval. These trials were based on the development of next-generation drug candidates such as ADCM (Antibody/Drug-Conjugated Micelles). In these drugs, selective targeting is enhanced through the development of the NanoFect System prototype for targeting nucleic acid, such as siRNA.
AccuRna Inc. (NANOCARRIER CO. LTD.) In Reports
Company's Business Segments
- Nucleic Acid Therapeutics : The company provides clinical therapeutic drugs for intractable and inherited rare diseases, mainly focusing on unique drug delivery platforms.
Applications/End User Industries
- Healthcare
- Life Sciences